Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
In November 2023, the FDA granted approval for Zepbound (tirzepatide) for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbid condition such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease
JBMR Plus (2021) 5(1):e10418
Understand Compounded Semaglutide and Its Role in Weight Loss Compounded tirzepatide is a customized formulation of the medication tirzepatide, primarily used for managing type 2 diabetes and supporting body mass reduction
Ask a doctor if necessary
Starting with a low dose and slowly increasing it helps reduce these problems
